Navigation Links
invivodata Offers Complimentary PRO Gap Analysis
Date:3/24/2010

evelop PRO instruments that are “fit for purpose” for specific program objectives and to integrate ePRO seamlessly into their clinical operations. For additional information and to register for PROficiency 2010, please visit invivodata.com/proficiency2010.

"invivodata’s PRO Consulting scientists have long contributed to and tracked the regulations and guidance surrounding patient-reported data collection in clinical research," said Dr. Jean Paty, invivodata Co-founder and Vice President of Scientific, Quality, and Regulatory Affairs. "We are pleased to offer the PRO Gap Analysis and share our expertise with clinical researchers as they work to understand the new FDA Guidance and make key decisions about their PRO strategies in global clinical development programs."
To request a complimentary PRO Gap Analysis teleconference, please visit invivodata.com/pro-gap-analysis.


About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consul
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. invivodata and PRO Consulting to Present at International Industry Events
2. invivodata Announces ePROficiency 2009 Web Seminar Series
3. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
5. INC Research and invivodata Announce ePRO Partnership
6. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
7. Radio wave cooling offers new twist on laser cooling
8. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
9. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
10. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
11. HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
(Date:7/29/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today announced ... Officer has resigned.  The Company has hired Andrew ... in December 2014, as full time interim CFO and ... Andy Ashworth began his employment today, ... transition.  Andy was the Company,s CFO from September 2011 ...
(Date:7/29/2015)... ... July 29, 2015 , ... Brady (NYSE:BRC), a global leader ... . To align chemical container labeling with OSHA’s updated Hazard Communication (HazCom) Standard ... an example of an accurate label, and pictogram uses and meanings. , “With ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Brady Announces a New GHS Label Guide 2
... June 3 OriGene Technologies, Inc., a leading gene-centric ... of over 5,000 heavy isotope labeled human proteins as internal standards ... The announcement was made at the 2010 American Society for ... , , ...
... 3 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that ... executive vice president and CFO, will provide an update on the progress of ... at two investor conferences during the month of June: , ... The Jefferies 2010 Global Life ...
... YORK , June 3 Reportlinker.com announces that a new market research report is ... Nanobiotechnologies- applications, markets and companies ... http://www.reportlinker.com/p0203545/Nanobiotechnologies--applications-markets-and-companies.html , , ... , , ...
Cached Biology Technology:OriGene Technologies Launches Over 5,000 Heavy Isotope Labeled Full-Length Human Proteins as Quantitative Internal Standards for SRM/MRM Mass Spectrometry 2Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences 2Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 3Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 4Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 5Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 6Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 7Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 8Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 9Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 10Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 11Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 12Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 13Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 14Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 15Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 16Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 17Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 18Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 19Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 20Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 21Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 22Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 23Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 24Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 25Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 26Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 27Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 28Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 29Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 30
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/13/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... method to make payments.  With this patent, NXT-ID ... its groundbreaking voice-direct payment patent application, with behavior-directed ...
(Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... School of Medicine in St. Louis, living cells gobbled ... of the unusual meal, the cells were easily located ... , Developed in the laboratories of Samuel A. Wickline, ... soon allow researchers and physicians to directly track cells ...
... As climate change continues to make headlines across the ... are hearing how Earth observation satellites allow scientists to ... how this is impacting the planet. , The cryosphere ... on climate. Because any increase in the melt rate ...
... two strategies to reactivate the p53 gene in mice, causing ... protein is called the "guardian of the genome" because it ... of p53 can set the stage for the development of ... first time that inactivating the p53 gene is necessary for ...
Cached Biology News:Nanoparticles can track cells deep within living organisms 2Nanoparticles can track cells deep within living organisms 3Satellites shed light on global warming 2Satellites shed light on global warming 3Satellites shed light on global warming 4Satellites shed light on global warming 5Turning a cellular sentinel into a cancer killer 2Turning a cellular sentinel into a cancer killer 3Turning a cellular sentinel into a cancer killer 4
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells....
fli-1...
Purified Mouse anti-Hu p120 Catenin (pT916) Storage Temperature: Refrigerate(2 to 8C)...
Request Info...
Biology Products: